ECOLAB INC. (ECL) FY2026 YTD Q2 Statement of Cash Flows

Income StatementCash FlowBalance Sheet

Statement of Cash Flows

2026-01-01 to 2026-06-30

Swipe to see the full flow
ECOLAB INC. cash flow reconciliation, Jan 1, 2026 through Jun 30, 2026One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Net income including noncontrolling interest → Net cash from operating activities: $975,300,000.00Depreciation → Operating adjustments reconciliation: $364,300,000.00Amortization → Operating adjustments reconciliation: $167,700,000.00Accounts payable → Operating adjustments reconciliation: $146,300,000.00Share-based compensation expense → Operating adjustments reconciliation: $75,100,000.00Deferred income taxes → Operating adjustments reconciliation: $34,900,000.00Other, net → Operating adjustments reconciliation: $28,100,000.00Pension and postretirement plan (income) expense, net → Operating adjustments reconciliation: $18,900,000.00Operating adjustments reconciliation → Net cash from operating activities: $200,100,000.00Operating adjustments reconciliation → Other assets: $208,600,000.00Operating adjustments reconciliation → Accounts receivable: $197,000,000.00Operating adjustments reconciliation → Inventories: $131,400,000.00Operating adjustments reconciliation → Other liabilities: $62,600,000.00Operating adjustments reconciliation → Pension and postretirement plan contributions: $32,800,000.00Operating adjustments reconciliation → Restructuring charges, net of cash paid: $2,800,000.00Long-term debt borrowings → financing reconciliation: $5,081,200,000.00Exercise of employee stock options → financing reconciliation: $94,800,000.00financing reconciliation → Net cash from financing activities: $3,928,600,000.00financing reconciliation → Reacquired shares: $669,300,000.00financing reconciliation → Dividends paid: $424,100,000.00financing reconciliation → Net repayments of commercial paper and notes payable: $98,200,000.00financing reconciliation → Deferred financing costs: $49,200,000.00financing reconciliation → Other, net: $6,600,000.00Net cash used in investing activities → investing reconciliation: $629,500,000.00Property and other assets sold → investing reconciliation: $2,000,000.00investing reconciliation → Capital expenditures: $588,600,000.00investing reconciliation → Acquisitions and investments in affiliates, net of cash acquired: $27,000,000.00investing reconciliation → Other, net: $15,900,000.00Exchange-rate effect → Cash sources and uses: $14,600,000.00Beginning cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations → Cash sources and uses: $646,200,000.00Net cash from operating activities → Cash sources and uses: $1,175,400,000.00Net cash from financing activities → Cash sources and uses: $3,928,600,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations: $5,135,300,000.00Cash sources and uses → Net cash used in investing activities: $629,500,000.00Other liabilities: -$62,600,000.00Other operating liabilities−$62.60 MAccounts payable: $146,300,000.00Accounts payable+$146.30 MOther assets: -$208,600,000.00Other operating assets−$208.60 MInventories: -$131,400,000.00Inventories−$131.40 MAccounts receivable: -$197,000,000.00Accounts receivable−$197.00 MSale of global surgical solutions business: $0.00Other, net: $28,100,000.00Other non-cash items+$28.10 MRestructuring charges, net of cash paid: -$2,800,000.00Restructuring charges−$2.80 MPension and postretirement plan contributions: -$32,800,000.00Pension & retiree contributions−$32.80 MShare-based compensation expense: $75,100,000.00Stock-based compensation+$75.10 MDeferred income taxes: $34,900,000.00Deferred taxes & credits+$34.90 MAmortization: $167,700,000.00Amortization expense+$167.70 MDepreciation: $364,300,000.00Depreciation expense+$364.30 MPension and postretirement plan (income) expense, net: $18,900,000.00Pension & postretirement expense+$18.90 MNet income including noncontrolling interest: $975,300,000.00Net income including noncontrolling interest+$975.30 MNet cash from operating activities: $1,175,400,000.00Operating cash+$1.18 BOperating adjustments reconciliation: $835,300,000.00Other, net: -$6,600,000.00Other financing, net−$6.60 MExercise of employee stock options: $94,800,000.00Stock option exercises+$94.80 MDividends paid: -$424,100,000.00Common dividends paid−$424.10 MReacquired shares: -$669,300,000.00Common stock repurchases−$669.30 MLong-term debt borrowings: $5,081,200,000.00Long-term debt issued+$5.08 BNet repayments of commercial paper and notes payable: -$98,200,000.00Short-term debt, net−$98.20 MDeferred financing costs: -$49,200,000.00Financing costs paid−$49.20 MNet cash from financing activities: $3,928,600,000.00Financing cash+$3.93 Bfinancing reconciliation: $5,176,000,000.00Other, net: -$15,900,000.00Other investing, net−$15.90 MAcquisitions and investments in affiliates, net of cash acquired: -$27,000,000.00Business & affiliate purchases−$27.00 MDivestiture of businesses, net of cash divested: $0.00Property and other assets sold: $2,000,000.00Asset sales+$2.00 MCapital expenditures: -$588,600,000.00PP&E purchases−$588.60 MNet cash used in investing activities: -$629,500,000.00. Cash required to fund net payments.Investing cash−$629.50 Minvesting reconciliation: $631,500,000.00Cash sources and uses: $5,764,800,000.00Beginning cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations: $646,200,000.00Beginning cash$646.20 MEnding cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations: $5,135,300,000.00Ending cash$5.14 BExchange-rate effect: $14,600,000.00FX effect+$14.60 MCASH RECONCILIATIONOperatingflowsFinancingflowsInvestingflowsFree cash flow$586.80 MOperating cash − cash spent on PP&ECash flow / Net income1.21×Operating cash flow ÷ net incomeNet cash change+$4.49 BEnding cash − beginning cash
Chart details

ECOLAB INC. cash flow reconciliation, Jan 1, 2026 through Jun 30, 2026

Cash flows for Jan 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations. Beginning cash: Dec 31, 2025. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Dec 31, 2025
646,200,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations
Operating activities
1,175,400,000 US dollars. Net cash provided.
Other liabilities
negative 62,600,000 US dollars
Accounts payable
146,300,000 US dollars
Other assets
negative 208,600,000 US dollars
Inventories
negative 131,400,000 US dollars
Accounts receivable
negative 197,000,000 US dollars
Sale of global surgical solutions business
0 US dollars
Other, net
28,100,000 US dollars
Restructuring charges, net of cash paid
negative 2,800,000 US dollars
Pension and postretirement plan contributions
negative 32,800,000 US dollars
Share-based compensation expense
75,100,000 US dollars
Deferred income taxes
34,900,000 US dollars
Amortization
167,700,000 US dollars
Depreciation
364,300,000 US dollars
Pension and postretirement plan (income) expense, net
18,900,000 US dollars
Net income including noncontrolling interest
975,300,000 US dollars
Investing activities
negative 629,500,000 US dollars. Net cash used.
Other, net
negative 15,900,000 US dollars
Acquisitions and investments in affiliates, net of cash acquired
negative 27,000,000 US dollars
Divestiture of businesses, net of cash divested
0 US dollars
Property and other assets sold
2,000,000 US dollars
Capital expenditures
negative 588,600,000 US dollars
Financing activities
3,928,600,000 US dollars. Net cash provided.
Other, net
negative 6,600,000 US dollars
Exercise of employee stock options
94,800,000 US dollars
Dividends paid
negative 424,100,000 US dollars
Reacquired shares
negative 669,300,000 US dollars
Long-term debt borrowings
5,081,200,000 US dollars
Net repayments of commercial paper and notes payable
negative 98,200,000 US dollars
Deferred financing costs
negative 49,200,000 US dollars
Operating adjustment reconciliation
835,300,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
5,176,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
631,500,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
14,600,000 US dollars
Ending cash on Jun 30, 2026
5,135,300,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations
Cash sources and uses
5,764,800,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
4,489,100,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
1.21×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
Operating cash flow
1,175,400,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
588,600,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
586,800,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income enters operating cash directly in the reconciliation. The adjustment junction contributes the remaining $200.10M after reconciling the other positive and negative adjustments. These connections depict an accounting reconciliation, not traced cash receipts.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 1,175,400,000 US dollars minus 588,600,000 US dollars equals 586,800,000 US dollars.
ECOLAB INC. (ECL) FY2026 YTD Q2 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!